Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemafibrate in statin-intolerant hypercholesterolemia
NCT05923281Phase 3Completed
- Sponsor
- Kowa Company, Ltd.
- Start
- May 2023
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pemafibrate in hypercholesterolemia, sponsored by Kowa Company, Ltd.. Started May 2023; status: completed.
02
Drugs
pemafibrate
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT05923281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05923281.